TCL Archive FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug July 26, 2013
TCL Archive New Breast Cancer Trials to Include Pre Vs. Post Operative Chemotherapy, CSF Pilot Studies August 5, 1988
TCL Archive Drug Development: Tivozanib Trial Discontinued Due to Insufficient Enrollment February 7, 2014
TCL Archive DCE Board Approves concept For New Studies On Black, White Differences In Cancer Rates July 13, 1984
